According to Novo Nordisk's published phase III clinical trial data submitted to the FDA, participants assigned to oral Wegovy experienced average weight reduction outcomes in the low-to-mid-teens percentage range over the study period, while placebo groups demonstrated substantially lower changes
[16] While some participants in clinical studies have reported menstrual changes, these are generally attributed to the metabolic effects of weight loss rather than direct drug action on reproductive tissues, and are not classified as common adverse effects in the UK product information for GLP-1 medications
Acute effects of glaucoma medications on rat intraocular pressure
[DOI] [PMC free article] [PubMed] [Google Scholar] 41.Frch K, Torekov SS, Vistisen D, Johansen NB, Witte DR, Jonsson A, et al
When glutathione levels do drop, your cells are more vulnerable to damage, which is why supplementation is essential for maintaining optimal health and wellness
